SS Innovations International (SSII) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Jun, 2026Vision and mission
Focus on developing advanced, affordable, and accessible surgical robotic systems for global patient benefit.
Commitment to continuous improvement and deployment of cost-effective technology.
Business snapshot and operations
Proprietary SSi Mantra 3 system supports multi-specialty surgeries, with 210 systems installed across 12 countries and 186 hospitals.
Over 11,270 surgeries performed, including 587 robotic cardiac surgeries, with zero significant safety events reported as of May 31, 2026.
Headquarters in India and Florida, 479 employees, and strong market presence in India.
Leadership and expertise
Led by experienced professionals with proven track records in surgical robotics, including pioneers in robotic cardiac surgery and founders of major medtech companies.
Significant insider ownership, with the founder holding over 54% of shares.
Latest events from SS Innovations International
- Advanced, affordable surgical robotics platform expands globally, outpacing competitors in key markets.SSII
Stifel 2025 Healthcare Conference17 Jun 2026 - Record revenue and margin growth, narrowing losses, and ongoing global expansion amid funding risks.SSII
Q1 202515 Jun 2026 - Q2 2025 saw record revenue, margin expansion, and urgent funding needs amid global milestones.SSII
Q2 202515 Jun 2026 - Q3 revenue jumped 192.5% to $12.8M, but ongoing losses and funding needs pose risks.SSII
Q3 202515 Jun 2026 - Revenue doubled and installations surged, with improved margins and narrowed net loss.SSII
Q4 202515 Jun 2026 - Record revenue and margin gains, narrowed loss, but funding risks persist amid global expansion.SSII
Q1 202615 Jun 2026 - IPO seeks up to $52.8M to fund global expansion amid rapid growth and ongoing losses.SSII
Registration filing15 Jun 2026 - Revenue surged 251% to $20.6M, but net loss remained high at $19.2M amid ongoing expansion.SSII
Q4 202415 Jun 2026 - Q2 2024 revenue surged, but losses widened and prior financials require restatement.SSII
Q2 202415 Jun 2026